title: [Clinical study on treatment of moderate and advanced stage cancers by Bailong Tablets combined with chemotherapy].
abstract: OBJECTIVE
  To assess the effects and mechanism of Bailong Tablet combined chemotherapy treatment.
  
  
  METHODS
  The test group, 41 cancer patients of moderate and advanced stage treated by chemotherapy plus Bailong tablet, and the control group, 22 cancer patients treated by chemotherapy alone. Observe the chemotherapy complete rates (CCR) and the immunological function of the cell in the two groups.
  
  
  RESULTS
  The CCR in the test group (92.6%) were higher than that of the control group (77.2%, P < 0.05). However, the toxic side-effect caused by chemotherapy in the test group were lower than that in the control group (P < 0.05). CD3 and the ratio of CD4/CD8 were obviously raised in the test group. The results indicates that the Bailong Tablets had the effects of regulating the immunological function of the T-cell.
  
  
  CONCLUSIONS
  Bailong tablet could enhance the efficacy and reduce the toxic side-effect of chemotherapy. Modulation of the cell immunological function is possibly its mechanism.
authors.affiliation: School of Oncology, Beijing Medical University, Beijing Institute for Cancer Research(100036).
authors.forename: X
authors.initials: X
authors.lastname: Zhang
authors.forename: S
authors.initials: S
authors.lastname: Liu
authors.forename: Y
authors.initials: Y
authors.lastname: Liang
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D016516:CD4-CD8 Ratio; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013607:Tablets
chemical_list: D000276:Adjuvants, Immunologic; D004365:Drugs, Chinese Herbal; D013607:Tablets